Alex is Sprintlaw’s co-founder and principal lawyer. Alex previously worked at a top-tier firm as a lawyer specialising in technology and media contracts, and founded a digital agency which he sold in 2015.
- Overview
FAQs
- Can a clinical trial service provider agree to unlimited liability?
- Are indemnities worse than ordinary liability clauses?
- Who should take responsibility for protocol related risks?
- Do data protection clauses need special attention in trial service agreements?
- What should a provider do before accepting a customer's standard terms?
- Key Takeaways
If you provide clinical trial services in the UK, the contract you sign with a sponsor, CRO, biotech company or other customer can decide who carries the commercial pain when things go wrong.
Founders often make the same mistakes: accepting a customer template without checking the indemnities, agreeing to performance obligations that depend on third parties, or assuming insurance will fix clauses that are too broad to insure properly. Those errors can turn a promising deal into a contract that exposes your business to delays, regulatory issues, data breaches, patient claims or open ended liability.
The hard part is that risk allocation clauses often look standard until you test them against the way a study actually runs. A single sentence about protocol compliance, adverse event reporting, sample handling or data accuracy can shift responsibility far beyond your fee. This guide explains how risk allocation works in customer contracts for UK clinical trial service providers, what to check before you sign, where businesses commonly get caught, and how to negotiate fairer terms that match your real role in the trial.
Overview
Risk allocation is the part of the contract that decides who is responsible for particular losses, delays, compliance failures and third party claims. For UK clinical trial service providers, that usually sits across the whole agreement, not just in one liability clause, so you need to read the operational provisions and the legal boilerplate together.
- define your services and assumptions with precision
- separate responsibility for sponsor decisions, site conduct and provider tasks
- cap liability sensibly and exclude losses that are out of proportion to the contract value
- limit indemnities so they match faults your business can actually control
- check data protection, confidentiality and IP clauses for hidden liability shifts
- align timelines, service levels and acceptance criteria with what is realistically deliverable
- make sure insurance obligations reflect available cover in the UK market
- set clear notice, escalation and remediation steps for errors, delays and claims
What Risk Allocation Customer Contract Clinical Trial Service Provider Means For UK Businesses
For a UK clinical trial service provider, risk allocation means deciding in advance which party bears which legal and financial consequences if the study does not go to plan. The main point is not to avoid all risk, it is to make sure your contract only gives you responsibility for matters your business can genuinely manage.
That sounds simple, but clinical trial delivery usually involves several moving parts. The sponsor may own the protocol and key scientific decisions. Sites may control patient interactions. Laboratories may handle testing. Technology vendors may host systems. Your contract should reflect that split, otherwise your business can end up carrying risk created by someone else.
Why this matters more in clinical trial services
Clinical trial projects create unusual pressure because operational errors can lead to regulatory consequences, data integrity concerns and serious commercial disruption. Even where a provider's role is narrow, the customer may try to push broader accountability into the contract.
Before you sign a contract, look past the headline fee and ask what happens if:
- recruitment is slower than forecast
- a site fails to follow the protocol
- samples are delayed or degraded in transit
- data is entered inaccurately or late
- a system outage affects access to study data
- a patient or third party brings a claim
- a regulator questions record keeping or reporting
- the sponsor changes scope halfway through delivery
If the contract does not answer those questions clearly, the default position may be uncertain, expensive to argue about, or unfairly weighted against you.
Where risk usually sits in the contract
Risk allocation is spread across multiple clauses. This is where founders often get caught, because they focus on the liability cap and miss the rest.
Pay close attention to:
- the scope of services, statements of work and project assumptions
- warranties about skill, care, compliance, timelines and outcomes
- indemnities for third party claims, IP issues, data breaches and regulatory breaches
- limitations and exclusions of liability
- change control, delays and dependency clauses
- confidentiality, data protection and security commitments
- acceptance testing, re-performance rights and service credits
- termination rights and what happens on exit
Risk allocation is not only about blame
A good contract does more than assign blame after a problem. It also sets workable procedures while the project is live. Clear notification periods, escalation routes, remediation rights and decision making rules can stop a small issue turning into a claim.
For example, if your business provides data management services, the contract should say when data queries are deemed accepted, what source materials you are entitled to rely on, and what happens if sponsor review is delayed. Without that detail, a customer may later argue that all knock on loss sits with you.
UK context and regulated activity
The UK regulatory environment matters, but a customer contract still needs careful contract drafting even where the law already allocates some responsibilities. Clinical trials may involve obligations under trial regulations, ethics approvals, pharmacovigilance arrangements, professional standards, the UK GDPR and confidentiality duties. Your contract should support those obligations, not blur them.
It is especially important not to promise that your services will ensure overall regulatory compliance for the whole study unless that is genuinely your role and you control the relevant processes. A better approach is to state the standard you will meet within your defined services, and to identify the customer dependencies that must be in place for you to perform.
Legal Issues To Check Before You Sign
Before you accept the provider's standard terms or the customer's paper, check whether the legal drafting matches the real workflow of the study. The safest contract is one that maps responsibility to actual control, evidence and decision making.
1. Scope of services and assumptions
The first protection is a precise description of what you are doing, and what you are not doing. If your role is limited to central monitoring, sample logistics, site support, data processing or software access, say so clearly.
Include a list of assumptions where relevant:
- the customer will provide an approved protocol and up to date study documents
- sites will obtain and maintain the required approvals and consents
- third party couriers, labs or platforms are outside your direct control unless expressly managed by you
- you may rely on information and instructions supplied by the customer or authorised study personnel
- timelines depend on customer review, approvals and timely access to systems and records
If assumptions are missing, they are harder to rely on later.
2. Standard of care, warranties and outcome promises
You should usually promise a reasonable standard of skill and care, not a guaranteed study result. Customers often draft obligations that effectively guarantee timelines, compliance outcomes or data accuracy across the whole project.
Watch for wording that says your business will:
- ensure the study complies with all applicable laws
- guarantee protocol adherence by sites or investigators
- deliver services free from any error or interruption
- meet all milestones regardless of sponsor delays or scope changes
- be responsible for any failure connected with the study
Those commitments may go far beyond what a service provider can reasonably control.
3. Indemnities
An indemnity can require your business to cover the customer's loss on a pound for pound basis, often without the same limits that apply to ordinary breach of contract claims. This is one of the most heavily negotiated parts of a clinical trial services agreement.
Before you sign, narrow any indemnity by reference to:
- faults caused by your negligence, breach of contract or unlawful act
- losses that are direct and reasonably connected to that fault
- claims from third parties, rather than all internal customer losses
- the customer's duty to notify, mitigate and let you control the defence where appropriate
- carve outs where the claim arises from the protocol, sponsor instructions, site conduct or customer supplied materials
The customer may also give you indemnities, for example for claims arising from the protocol, investigational product, sponsor negligence or infringement in customer materials. Those reciprocal protections matter.
4. Limits of liability
A liability cap is often the backstop that keeps one project from threatening the whole business. The right cap depends on your role, fee level, insurance and bargaining power, but unlimited exposure is rarely sensible for an SME provider.
Check:
- the amount of the overall cap, and whether it relates to annual fees, project fees or a multiple of fees
- whether special caps apply to data protection, confidentiality, IP infringement or indemnities
- which losses are excluded, such as indirect loss, loss of profit, loss of revenue, loss of opportunity or loss of anticipated savings
- whether the contract tries to label broad categories of foreseeable commercial loss as direct loss
- whether the cap applies per claim or in aggregate
Under UK law, liability exclusions and limits need to be drafted carefully and may be subject to reasonableness controls in some business to business settings. A clause that looks aggressive on paper may not be the final word, but relying on that is not a good strategy. Better drafting upfront is cheaper.
5. Data protection and confidentiality
Clinical trial arrangements often involve personal data, sometimes special category data, plus highly sensitive confidential information. A data protection clause should reflect the actual roles of the parties, for example controller, joint controller or processor, rather than using a generic template.
Key points include:
- who decides the purposes and means of processing
- what instructions you are entitled to follow
- security standards that are realistic and measurable
- what happens with sub-processors and overseas transfers
- notification and cooperation rules for personal data breaches
- limits on liability for data claims and regulatory action
Confidentiality clauses also need care. Some customer drafts impose perpetual confidentiality on all operational information, with immediate injunctive style remedies and no practical exceptions. You need standard carve outs for information already known, independently developed, public, or required to be disclosed by law or regulators.
6. Intellectual property and study materials
IP ownership can create hidden risk if the contract is unclear about pre-existing tools, templates, software, databases and know how. You usually want to keep ownership of your background IP and grant a limited licence where needed.
Spell out:
- what each party owned before the contract
- who owns project specific deliverables
- whether the customer gets a licence or outright assignment
- whether anonymised know how, methods and general learnings remain yours
- what indemnity applies if customer supplied materials infringe third party rights
7. Change control, delays and dependencies
Most project disputes start with scope drift, not a dramatic single breach. If the protocol changes, recruitment assumptions fail or the customer adds reporting requirements, the contract should let you adjust timing and fees.
Use a change control mechanism that covers:
- how changes are requested and approved
- what happens if urgent work is needed before paperwork is finalised
- how revised fees and timelines are calculated
- what relief you get for customer delays or missing dependencies
- when milestones move automatically because inputs were late
8. Insurance and claims handling
Insurance should support the contract, not patch over careless drafting. Check whether the policy types and limits requested are available and sensible for your business.
You should also review claims handling provisions, including:
- who notifies insurers and when
- whether admissions of liability are restricted
- who controls settlement and defence strategy
- what cooperation each party must give
If a customer asks for insurance levels far above market norms for your service line, that is often a sign the underlying risk allocation is skewed.
Common Mistakes With Risk Allocation Customer Contract Clinical Trial Service Provider
The most common mistake is treating risk allocation as a final legal tidy up instead of a commercial decision. If the operations team promises one thing and the contract says another, the contract usually wins the argument.
Accepting broad responsibility for the whole trial
A provider may only manage one workstream, but the contract says it is responsible for all applicable laws, all study delays and all losses connected with the project. That is too broad for most service providers.
The fix is to tie each obligation to your specific services and the matters within your control.
Leaving customer dependencies out of the contract
Founders often rely on emails and kick off calls where everyone agrees that sponsor approvals, site access and document completeness are customer responsibilities. If those dependencies never make it into the written terms, they may be hard to enforce.
Before you rely on a verbal promise, put the dependency, timing assumption and consequence of delay in the signed document.
Overlooking hidden uncapped liability
Some contracts show a reasonable general cap, then remove the cap for confidentiality, data protection, indemnities, fraud, regulatory breach and IP infringement. In practice, that can leave the most likely claim areas uncapped.
Read the carve outs together. A capped clause with several wide exceptions may not protect you much at all.
Promising outcomes instead of process
Clinical trial service providers sometimes agree to language that sounds harmless, such as guaranteeing compliant data, complete records or uninterrupted systems. If your service depends on customer actions, site conduct or external technology, outcome promises create unfair exposure.
Use process based wording where possible. Promise to perform services with reasonable skill and care, in accordance with agreed procedures, and subject to stated assumptions.
Forgetting subcontractors and vendors
If you use couriers, labs, software providers or freelance specialists, the customer contract should allow that model and reflect realistic responsibility. You may still remain responsible for subcontracted performance, but your risk should not exceed what you can practically manage and flow down.
Check whether your own supplier contracts support the promises you are giving upstream.
Ignoring termination and exit risk
A badly drafted exit clause can leave you unpaid for committed costs, transition work or partially completed milestones. Customers may want broad termination rights for convenience, especially in research settings where funding or strategy changes quickly.
Make sure the contract covers:
- payment for work done up to termination
- recovery of non-cancellable third party costs
- reasonable transition assistance terms and fees
- what data, materials and records must be returned or deleted
- which clauses continue after termination
Using the same template for every project
A central monitoring project, laboratory services agreement and software enabled trial support arrangement do not present the same risks. Reusing a single template without adapting the liability model often leads to gaps or unnecessary concessions.
This is where founders often get caught when sales moves quickly and legal review happens late. Before you sign, sense check whether the paper fits the actual service line.
FAQs
Can a clinical trial service provider agree to unlimited liability?
It can, but that is often a poor fit for an SME unless the pricing, insurance and project control justify it. Many providers negotiate an overall cap with narrower exceptions for specific high risk areas.
Are indemnities worse than ordinary liability clauses?
Often yes, because an indemnity may bypass some of the limits and arguments available in an ordinary damages claim. The wording matters, so indemnities should be narrow, fault based and clearly tied to your actual role.
Who should take responsibility for protocol related risks?
Usually the sponsor or the party controlling the protocol should carry risks arising from protocol design, sponsor instructions and investigational product issues. A service provider should only take responsibility for following agreed procedures within its defined services.
Do data protection clauses need special attention in trial service agreements?
Yes. Trial arrangements often involve sensitive personal data, multiple parties and strict operational rules. The contract should reflect the real data roles, security expectations and liability position, not generic wording copied from another sector.
What should a provider do before accepting a customer's standard terms?
Compare the legal wording with the statement of work, internal processes, insurance cover and subcontracting model. If the contract makes you responsible for matters outside your control, negotiate the scope, assumptions, indemnities, caps and change process before you sign.
Key Takeaways
- Risk allocation in a customer contract decides who bears losses, delays and third party claims when a clinical trial project runs into trouble.
- For UK clinical trial service providers, the safest position is to accept responsibility only for tasks your business actually controls and can evidence.
- Do not assess liability clauses in isolation. Scope, warranties, indemnities, data protection, IP, change control and termination all affect where risk sits.
- Broad indemnities, outcome guarantees and hidden uncapped carve outs are common pressure points in customer paper.
- Customer dependencies, sponsor responsibilities, site conduct and third party vendor risks should be stated clearly in the signed agreement.
- A fair contract should align with your fees, insurance, operational model and the real allocation of responsibility across the study.
If you want help with liability caps, indemnities, data protection clauses, and scope of services, you can reach us on 08081347754 or team@sprintlaw.co.uk for a free, no-obligations chat.






